Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Participation Type:

HIVR4P Home

HIVR4P 2016 is made possible in part by the generous support of the American people through 1 R13 AI122959-01 from the National Institute of Allergy and Infectious Diseases (NIAID), and from the United States Agency for International Development (USAID). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services or USAID; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 sessions: 1 to 1 of 1
Press Conference: Research Highlights from HIV R4P
Helen Rees
Wits Reproductive Health and HIV Institute (Wits RHI), South Africa
Anatoli Kamali
MRC/UVRI Uganda Research Unit on AIDS, Uganda
Carl Dieffenbach
National Institutes of Health, US
William Spreen
GlaxoSmithKline R&D, US
Ian McGowan
University of PIttsburgh School of Medicine, US
Jeanne Marrazzo
University of Washington, US
Glenda Gray
South African Medical Research Council and HIV Vaccine Trials Network, SA
from HIV Research for Prevention 2014 on 28 October 2014 12:30-13:30
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 sessions: 1 to 1 of 1